References
- Connor TH, MacKenzie BA, DeBord DG, et al. NIOSH List of
Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016,
Publication Number 2016-161 (Supersedes 2014-138). OH: U.S. Department
of Health and Human Services, Centers for Disease Control and
Prevention, National Institute for Occupational Safety and Health,
DHHS (NIOSH), 2016
- Celano
P,
Fausel
CA,
Kennedy
EB, et al. Safe handling of hazardous drugs: ASCO standards.
J Clin Oncol
2019;37: 598–609.
- US Pharmacopeia. General Chapter <800>
Hazardous Drugs—Handling in Healthcare Settings
- Polovich
M,
Olsen
M. Safe handling of hazardous drugs. 3rd Ed. Oncology Nursing Society,
2018
- Dillon
LR. Quality control: personal protective equipment for use when
handling hazardous drugs.
Int J Pharm Compd
2020; 24:30–36.
- Makino T, Hasegawa N, Takizawa R, et al. Suggestions for
Protecting Breast Cancer Patients Receiving Outpatient Chemotherapy
and Their Families Against the Exposure Risk from Salivary
Cyclophosphamide. Int J Nurs Clin Pract 2020;7: 320, doi:
https://doi.org/10.15344/2394-
4978/2020/320
- Gourd
E. New drug-transfer device reduces hazardous exposure. Lancet Oncol
2017;18: e312.
- Voelcker
G. Causes and possibilities to circumvent cyclophosphamide toxicity.
Anticancer Drugs
doi: 10.1097/CAD.0000000000000912, 2020 Feb
8
- Gajski
G,
Ladeira
C,
Gerić
M, et al. Genotoxicity assessment of a selected cytostatic drug
mixture in human lymphocytes: A study based on concentrations relevant
for occupational exposure.
Environ Res
2018;161:
26–34.
- Sessink PJ. Environmental contamination with cytostatic
drugs: past, present and future. Saf Consid Oncol Pharm Special
Edition
2011